CLYM
Climb Bio, Inc. Common StockstockNASDAQ
Market OpenNov 19, 2026 3:23:51 PM EST
9.30USD0.000%(0.00)337,158
Pre-marketNov 19, 2026 9:13:30 AM EST
9.48USD+1.935%(+0.18)
CLYM News
Wedbush keeps Climb Bio on Best Ideas List, raises price target ·
Investing.com
Oppenheimer reiterates Climb Bio stock rating on SLE data ·
Investing.com
Baird reiterates Climb Bio stock rating on clinical progress ·
Investing.com
Climb Bio Non-GAAP EPS of -$0.18 beats by $0.02 ·
Seeking Alpha
Climb Bio Reports Third Quarter 2026 Financial Results and Provides Business Updates ·
GlobeNewswire Inc.
Piper Sandler reiterates Climb Bio stock rating after ASN data ·
Investing.com
Climb Bio reports early data on budoprutug for kidney diseases ·
Investing.com
Climb Bio reports Phase 1 data for IgAN drug candidate ·
Investing.com
Why is Climb Bio stock surging today? ·
Investing.com